Curaleaf Holdings, Inc. (CURA)
TSX
Closed
Aug 25, 2026
Day's Range
13.2952 wk Range
7.77Overview - CURA - Curaleaf Holdings, Inc.
Key Statistics
Valuation
Enterprise Value
6.40B
P/E (Trailing)
‪-12.95‬
P/E (Forward)
‪-17.40‬
PEG Ratio
‪0.10‬
Price / Sales (TTM)
‪2.70‬
Price / Book
‪2.97‬
EV / EBITDA
‪22.18‬
Profitability
Gross Margin
‪49.96%‬
Profit Margin
‪-2.62%‬
Operating Margin
‪1.24%‬
Return on Assets
‪0.32%‬
Return on Equity
‪-2.35%‬
Ownership
Shares Outstanding
264.73M
Float
226.59M
Held by Insiders
‪25.78%‬
Held by Institutions
‪7.61%‬
Price stats
Beta
‪1.62‬
50-Day Avg
‪13.40‬
200-Day Avg
‪11.85‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
6 analysts
Average price target
‪CA$ 18.31‬Market Cap - CURA - Curaleaf Holdings, Inc.
Peers - CURA - Curaleaf Holdings, Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on TSX.
Profile Summary - CURA - Curaleaf Holdings, Inc.
About
Curaleaf Holdings, Inc. is a leading international cannabis company focused on producing and distributing medical and adult-use cannabis products. It operates a vertically integrated model, encompassing cultivation, processing, branding, and retail through its network of dispensaries across multiple states in the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
